Several innovative medications are transforming glucose management, with Retatrutide, Cagrillintide, Tirzepatide, and Semaglutide being highlighted leading options. Retatrutide, a twin GIP and GLP-1 receptor activator, exhibits remarkable fat reduction coupled with better glycemic levels. Cagrill